TUM – Latest news https://www.tum.de Latest news of TUM en TUM Fri, 26 Feb 2021 20:33:44 +0100 Fri, 26 Feb 2021 20:33:44 +0100 Rotor head full fairing makes the RACER fly faster https://www.tum.de/en/about-tum/news/press-releases/details/36450/ Vertical take-off and landing aircraft are essential whenever there's not enough room for runways, for example in mountain rescue missions, flights to oil platforms or when providing medical services to remote areas. But conventional helicopters consume more energy and achieve lower speeds in forward flight than fixed-wing aircraft. This is because the helicopter requires a rotor for vertical take-off and landing and to maintain a steady position in the air; however, the rotor has high aerodynamic drag when cruising.

With the Airbus demonstrator RACER (Rapid And Cost-Effective Rotorcraft), scientists are working to develop an aircraft that can reach a speed of 400 kilometers per hour in forward flight and which is in addition quieter and greener than existing helicopters. The innovative RACER not only has a rotor, but also features wings like an airplane in order to generate aerodynamically efficient lift and to reduce the load on the rotor.

Research news stefanie.reiffert@tum.de news-36449 Wed, 24 Feb 2021 11:59:00 +0100
Covid-19: Insights into current research https://www.tum.de/en/about-tum/news/press-releases/details/36381/ The lecture series was held in German and English language.

Covid-19 news-36379 Wed, 17 Feb 2021 11:00:00 +0100
A memory without a brain https://www.tum.de/en/about-tum/news/press-releases/details/36462/ The ability to store and recover information gives an organism a clear advantage when searching for food or avoiding harmful environments. Traditionally it has been attributed to organisms that have a nervous system.

A new study authored by Mirna Kramar (MPI-DS) and Prof. Karen Alim (TUM and MPI-DS) challenges this view by uncovering the surprising abilities of a highly dynamic, single-celled organism to store and retrieve information about its environment.

Research news battenberg@zv.tum.de news-36459 Tue, 23 Feb 2021 08:29:52 +0100
Even multi-story timber buildings can safely survive compartment fires https://www.tum.de/en/about-tum/news/press-releases/details/36458/ Climate change, energy transformation, sustainability: Wood is trending as a renewable building material, with demand for timber buildings on the rise. However, wood's ability to store carbon gives it a certain natural property: In contrast to building materials like steel reinforced concrete and masonry, wood is a combustible material. Although it is no longer only single-family houses that are built of wood, only limited legal regulations exists for the fire-safe construction of multi-story timber buildings.

"Our objective is to enable a legally compliant construction of timber buildings up to the high-rise level of 22 meters throughout Germany," says Thomas Engel from the TUM Chair of Timber Structures and Building Construction. Together with Technische Universität Braunschweig, Magdeburg-Stendal University of Applied Sciences and the Institute of Fire and Civil Protection Heyrothsberge (IBK), the TUM research group has been working towards this goal in the project TIMpuls for approximately four years.

Research news stefanie.reiffert@tum.de news-36456 Mon, 22 Feb 2021 09:56:00 +0100
Artificial intelligence deciphers genetic instructions https://www.tum.de/en/about-tum/news/press-releases/details/36455/ Artificial intelligence algorithms are extremely powerful at fitting massive and complex datasets. But their interpretation, rationalizing how the machine performs specific predictions when presented a given input, is notoriously hard. This black box behavior hampers wide acceptation of AI in medical diagnostics, where justifications matter, and restrain their utility in natural sciences where understanding mechanisms is the goal.

Now, an interdisciplinary team of biologists and computational researchers from the Technical University of Munich, the Stowers Institute for Medical Research and the Stanford University has shown that applying neural networks, such as those used for facial recognition, together with newly developed model interpretation techniques can be used to decipher complex instructions encoded in DNA. 

One of the big unsolved problems in biology is the genome’s second code, its regulatory code. The DNA bases encode not only the instructions for how to build proteins, but also when and where to make these proteins in an organism. 

The regulatory code is read by proteins called transcription factors that bind to short stretches of DNA called motifs. However, how particular combinations and arrangements of motifs specify regulatory activity is an extremely complex problem that has been hard to pin down.

Artificial Intelligence Research news andreas.battenberg@tum.de news-36454 Thu, 18 Feb 2021 11:07:22 +0100
Cloudy eyes caused by protein imbalance https://www.tum.de/en/about-tum/news/press-releases/details/36453/ The cells in the lens consist of a highly concentrated protein solution that is normally clear. “When the balance of the proteins in the lens is destroyed, they clump together and the lens becomes cloudy,” says Prof. Johannes Buchner of the Chair of Biotechnology at TUM. This results in the condition known as cataracts.

The clouding can have different causes. Because the proteins in the lens are formed in the embryo and are not replaced, damage can accumulate over the years, ultimately causing the lens to cloud over. That is why cataracts occur mainly in older people. But some individuals have a genetic predisposition to the eye condition, in which proteins in the lens mutate. In these cases, cataracts are present at birth or appear during childhood.

Research news stefanie.reiffert@tum.de news-36452 Tue, 16 Feb 2021 08:42:01 +0100
Synthetic “mini” receptors block atherosclerosis https://www.tum.de/en/about-tum/news/press-releases/details/36446/ Research over the last 20 years has shown that atherosclerosis is a chronic inflammatory condition of the arterial blood vessel wall. Soluble mediators such as cytokines and chemokines are pivotal players in this disease, promoting vascular inflammation. However, the development of anti-inflammatory therapeutics directed against such mediators that could prevent atherosclerosis has proven difficult, despite promising clinical studies in the recent past.

Previous anti-inflammatory therapeutic strategies to prevent atherosclerosis, heart attacks, strokes, rheumatoid arthritis and other inflammatory diseases have mainly been based on antibodies and small molecule drugs. The Munich-based research team has now designed and chemically synthesized short chains of amino acids – i.e. peptides – that function like a minimized soluble chemokine receptor. In animal models, these peptides can block atherosclerosis.

Research news katharina.baumeister@tum.de news-36441 Fri, 12 Feb 2021 17:24:00 +0100
Medication-based starvation of cancer cells https://www.tum.de/en/about-tum/news/press-releases/details/36448/ The drug thalidomide was sold as a sedative under the trade name Contergan in the 1950s and 1960s. At the time, its side-effects triggered one of the largest pharmaceutical scandals in history: The medication was taken from the market after it became known that the use of Contergan during pregnancy had resulted in over 10,000 cases of severe birth defects.

Currently, the successor preparations lenalidomide and pomalidomide are prescribed under strict supervision by experienced oncologists – the active ingredients are a cornerstone of modern cancer therapies. The use of lenalidomide and pomalidomide has considerably improved the success rate of therapies and patient survival, particularly for hematological malignancies such as multiple myeloma. Since these substances can influence the immune system, they are referred to as immunomodulatory drugs (IMiDs).

Research news lisa.pietrzyk@tum.de news-36447 Fri, 12 Feb 2021 07:11:40 +0100
Captured lithium https://www.tum.de/en/about-tum/news/press-releases/details/36444/ The outstanding characteristics of the lithium-ion battery have changed our everyday lives as only very few other inventions have. However, over time various effects occur which gradually reduce the great storage capability of these batteries.

At the Technical University of Munich’s Research Neutron Source Heinz Maier-Leibnitz (FRM II) Dr. Anatoliy Senyshyn, instrument scientist at the high-resolution powder diffractometer SPODI, used neutron scattering to investigate the cause of these effects in cylindrical lithium-ion batteries. 

Together with other scientists he is searching for answers to fundamental questions on the structure and behavior of rechargeable lithium-ion batteries: Why does the available capacity drop over time? How is the lithium distributed in the battery?

Research news andreas.battenberg@tum.de news-36443 Wed, 10 Feb 2021 11:43:16 +0100
From the lab to the start-up – with a lot of psychology https://www.tum.de/en/about-tum/news/press-releases/details/36445/ Scientists are constantly developing ideas and new technologies with the potential to generate new products and services. That would seem to make them ideal candidates to launch a start-up. However, successful companies founded by scientists have remained relatively uncommon in Germany.

To learn why, a team of researchers led by the Technical University of Munich (TUM) and representing the fields of entrepreneurship, psychology, anthropology and economics investigated the psychology in start-up processes, applying four different perspectives and methods: First, they spent several months surveying around 280 start-up founders across Germany to learn about the influence of psychological factors such as motivation, stress and frustration, personality structure and trust impact success. Second, they worked with around 50 start-up teams in experimental settings to analyze by video how they exchange information and make decisions.

Furthermore, the team observed and interviewed around 200 participants at four makeathons at TUM. In makeathons, teams spend from three days to two weeks developing an entrepreneurial idea and a product with the support of coaches. A member of the research team acted as such a coach, utilizing a familiar method from anthropology in which researchers become part of the object of their research while making observations. And finally, the group spent nine months interviewing 12 differently composed start-up teams to analyze in detail how academic teams work together in the start-up process.

Entrepreneurship Research news news-36442 Wed, 10 Feb 2021 10:49:00 +0100
Professional traineeships at EPO for TUM graduates https://www.tum.de/en/about-tum/news/press-releases/details/36438/ Signed by EPO President António Campinos, EUIPO Executive Director Christian Archambeau and TUM President Thomas F. Hofmann, this agreement paves the way for TUM graduates to participate in the Pan-European Seal Professional Traineeship Programme, a vibrant network of over 80 academic institutions across Europe with a pronounced interest in intellectual property (IP) such as patents, registered designs and trademarks.

“The EPO is honoured to have this opportunity to support young people in Munich. In these challenging times, and in light of the crucial role played by IP in Europe’s economy, it is more important than ever to create prospects for local graduates and invest in the IP minds of tomorrow so that they can act as ambassadors for IP and the benefits it brings,” said EPO President António Campinos. “As a public institution with long-standing ties to Munich, this agreement will enable the EPO to work with the TUM and utilise its resources to generate benefits for local citizens and society as a whole”.

Thomas F. Hofmann, TUM President said: “We firmly believe that close cooperation among the stakeholders in the IP community will lead to mutual benefits and ultimately to the benefit of society through the commercialization of technologies, which in turn leads to the development of innovative products and solutions to technical problems, generates revenue, and creates jobs. Supported by its entrepreneurial mind-set, TUM has substantially increased the numbers of applications for European patents in recent years.”

Campus news presse@tum.de news-36437 Wed, 10 Feb 2021 08:33:00 +0100
Hydrogen: Energy of the Future? https://www.tum.de/en/about-tum/news/press-releases/details/36440/ Mobility TUM in the media battenberg@zv.tum.de news-36439 Mon, 08 Feb 2021 13:44:25 +0100 M Cube future cluster wins federal funding https://www.tum.de/en/about-tum/news/press-releases/details/36436/ With the Clusters4Future competition, the Federal Ministry of Education and Research aims to promote the rapid transfer of ideas from the world of research into real-world applications. A total of 137 projects entered the competition to earn designation as a future cluster. Seven projects nationwide have now been selected to receive funding, including the M Cube cluster coordinated by TUM.

Mobility Research news news-36435 Wed, 03 Feb 2021 11:53:41 +0100
When hyperactive proteins trigger illnesses https://www.tum.de/en/about-tum/news/press-releases/details/36430/ The immune system can be a mixed blessing: Usually it is highly effective in protecting the human organism against bacteria, viruses and mycosis and even cancer. But these defense cells can also turn against the body's own tissues and trigger autoimmune diseases, including for example rheumatoid arthritis and systemic lupus erythematosus, an illness involving chronic dermatitis and inflammation of the joints, the nervous system and internal organs or even become cancer cells themselves and develop into leukemias or lymphomas. But what causes these destructive immune system attacks?

"The question has yet to be finally resolved," says Prof. Jürgen Ruland, Director of the TUM Institute for Clinical Chemistry and Pathobiochemistry. "B cells, a subgroup of white blood corpuscles produced in the bone marrow, play a central role in regulating immune responses. During a normal immune response, activated B cells produce antibodies which attack foreign substances. Defective activation can result in formation of antibodies which attack the body itself, triggering an autoimmune disease. The activity of B cells is controlled by a variety of signals, some of which we have yet to understand," observes Ruland. The immunologist and physician is also the winner of the 2021 German Research Foundation (DFG) Leibniz Prize.

Ruland and his team have succeeded in identifying one decisive signal which influences B cell activity: "The objective of our research was to characterize the possible pathological roles of a protein located on the surface of the B cells. This receptor, the Receptor Activator of NF-κB, or RANK, exhibits increased activity in patients with systemic lupus erythematosus and in some B cell lymphomas. We wanted to find out if hyperactive RANK receptors actually trigger theseis illnesses."

Research news lisa.pietrzyk@tum.de news-36429 Thu, 28 Jan 2021 15:34:28 +0100
Fair allocation in times of pandemic https://www.tum.de/en/about-tum/news/press-releases/details/36433/ "The whole world wants a vaccine. And at first – as was to be expected – there isn't enough to go around. A situation like this where the vaccine is absolutely scarce calls for proper prioritization," said Buyx. The vaccines against Sars-CoV-2 approved in Germany are therefore being allocated according to a five-tier prioritization model. Since the risk of a severe or fatal Covid-19 infection is 500 times higher for people over the age of 80 than for the young and healthy population, the elderly are currently very high on the allocation list. However, allocation in practice could change in case of new vaccines.

„The ethical difficulties are often a matter of detail.”— Prof. Alena Buyx

Buyx said that there are enormous challenges involved when it comes to practically implementing the ethical guidelines she has carefully formulated together with the members of the German Ethics Council, the Standing Committee on Vaccination (STIKO) and the Leopoldina German National Academy of Sciences. One example is the vaccine from AstraZeneca approved on Friday by the European Medicines Agency (EMA). According to STIKO the available data on the vaccine's efficacy for those over 65 years of age are insufficient. Buyx said that possible differences in the efficacy of a vaccine for different age groups have to be considered in vaccine distribution.

The medical ethicist went on to say that the reason primarily the elderly are being vaccinated is the basic principle of recognizing under the law not only the equality of all people, but also their differences. "An individual with an entirely different risk level may also receive different treatment," she added, noting that nevertheless the practical guidelines resulting from legal-ethical prerequisites require constant adaptation and ongoing further development – especially when important medical data are not yet available. "The ethical difficulties are often a matter of detail," said Buyx.

„We're in a very steep learning curve.”— Prof. Alena Buyx

The lack of reliable data is however also relevant in another context, as when it comes to the fair distribution of vaccines, she said. Buyx noted for example that at present it cannot be assumed with certainty that vaccinated individuals will not nevertheless infect others with the virus. If it was certain, she said, that by being vaccinated younger people could protect older people against infection, the fact would also have an impact on prioritization. "We're in a very steep learning curve," said Buyx. She pointed out that the most important factor in vaccine allocation is that it has to be transparent, robust and understandable; this can in turn inspire trust. Of course, it will never be possible to design the allocation process so that everyone will be satisfied, she conceded.

In her lecture Buyx also spoke on triage, i.e. the prioritization of patients requiring acute treatment in cases where medical capacities are inadequate. While triage happily still remains a theoretical consideration in Germany, the German Ethics Council and its Chair Alena Buyx are developing recommendations for vaccine allocation as the basis for current policy decisions. "I find the situation in part fairly bizarre," said the medical ethicist. During almost 20 years working with the allocation of scarce medical resources, Buyx said, she has often been asked why she was dealing with such a theoretical topic. But since early 2020 the topic has become highly relevant and could hardly have a more pragmatic focus.

Covid-19 lisa.pietrzyk@tum.de news-36432 Mon, 01 Feb 2021 17:10:00 +0100
Linde supports promotion of young scientists in data science at TUM https://www.tum.de/en/about-tum/news/press-releases/details/36428/ “Linde is committed to advancing STEM education in collaboration with impressive, forward-looking universities such as TUM,” said Lisa Esneault, VP Corporate Communications & Global Giving. “As part of our long-standing relationship with the university, we are proud to provide scholarships to doctoral and master's students at MDSI."

TUM President Thomas F. Hofmann thanked Linde for its generous support: "With this fellowship program, Linde is investing in the future of the next generation of data scientists. We have in particular female data scientists in mind with this project. Because unfortunately, women are still heavily underrepresented in this field. At TUM, we give them every opportunity to learn, do research and ultimately turn their ideas into applications."

Artificial Intelligence Campus news presse@tum.de news-36427 Wed, 27 Jan 2021 20:23:45 +0100
New promising target for diabetes treatment https://www.tum.de/en/about-tum/news/press-releases/details/36426/ Diabetes mellitus is a complex disease characterized by the loss or dysfunction of insulin-producing beta cells in the islets of Langerhans, a specialist “micro-organ” in the pancreas that controls systemic blood sugar levels. Diabetes complications, such as chronic high blood sugar, systemic metabolic failure and, in the long-term, multi-organ damage, create enormous medical and social burdens and leads to premature death. Currently no pharmacological treatment can stop or reverse disease progression. Previous studies have demonstrated that intensive insulin therapy has the potential for improved blood sugar control. However, intensive insulin therapy has serious side effects, such as an increased risk of deep drop in blood sugar causing unawareness.

„A hundred years ago, the discovery of insulin has transformed a deadly illness into a manageable disease. Our discovery is another important step to finally get rid of the disease.”— Prof. Matthias Tschöp

Research news lisa.pietrzyk@tum.de news-36425 Wed, 27 Jan 2021 15:26:37 +0100
Immune cells attack synapses https://www.tum.de/en/about-tum/news/press-releases/details/36422/ Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system, in which nerve cells are attacked by the patient’s own immune system. In many cases, the disease develops into a progressive form, which is characterized by a shift of pathology from the white matter to the gray matter, for instance to the cerebral cortex. This phase of the disease has so far been difficult to treat and its underlying causes are poorly understood.

Now, a research team at TUM, Ludwig-Maximilians-Univeristät in Munich (LMU) and the University of Geneva has shown in a mouse model that inflammation of the gray matter leads to a decrease in nerve-cell activity, owing to the (potentially reversible) destruction of synapses. “This finding could make it possible to curb synapse loss with certain anti-inflammatory measures,” says Thomas Misgeld, Professor for Neuronal Cell Biology at TUM.

Research news lisa.pietrzyk@tum.de news-36421 Tue, 26 Jan 2021 10:30:58 +0100
TUM founds Institute for LifeLong Learning https://www.tum.de/en/about-tum/news/press-releases/details/36423/ At the virtual founding event on Monday TUM President Thomas F. Hofmann asserted, "I'm convinced: Continuous learning will become an imperative for the resilience of our economy and our society! This means we have to ramp up our most important innovation driver – people! The extent to which we benefit from transformation is not only a question of technological expertise, it is much more a cultural challenge."

"Today with the TUM IL3 we are activating one of the most important core measures of our TUM AGENDA 2030 as part of the Excellence Strategy of the German federal and state governments," said Hofmann. Here TUM is developing beyond the classic university model to become a real "hub of knowledge exchange". Experts and leadership staff from the economic sector, politics and society can continuously return to TUM as "adult learners" in order to further certify their expertise in scientifically robust curricula.

Starting point for expert and leadership staff

The Founding Director of the new TUM IL³ is Senior Vice President - Talent Management and Diversity Prof. Claudia Peus: "We want to create THE starting point for expert and leadership staff from the widest possible variety of backgrounds, business sectors and nationalities in the German-speaking countries, even in all of Europe. As the best university in the EU, a status confirmed by last year's QS World Ranking, we are in an excellent position to achieve exactly that."

Professor Peus also pointed out that TUM IL³ is anything but a carbon-copy of continuing management education efforts by typical, private business schools. "Our program incorporates our entire scientific spectrum, ranging from engineering and natural sciences to life sciences and social sciences, all the way to medicine. And we can ensure that our content always matches the latest state of research."

A clear perspective on the topics of the future

Bavaria's Minister of Science Bernd Sibler stated: "TUM's excellence is also manifested in its clear perspective on the topics of the future. TUM uses ground-breaking concepts to tackle new challenges and set international standards, as is clearly illustrated at the TUM Institute for LifeLong Learning. Academic continuing education opportunities like those provided by TUM are of increasing importance today, a fact reflected in our new university innovation act."

Leading companies share focus on continuing education

TUM is collaborating closely with leading companies in the development of continuing education opportunities and is aligning topics with actual demand in the economic sector. Petra Scharner-Wolff, member of the Executive Board of the Otto Group, remarked at the TUM IL³ founding event that she is "a zealous advocate of lifelong learning", adding that learning has to become part of our everyday experience. Given the dramatic transformations taking place in the economy, she said, continuing education is "not a nice-to-have, it is a crucial element in a company's ability to survive."

Dr. Victoria Ossadnik, Chairwoman of the Board of Management of E.ON Energie Deutschland GmbH, called for "learning things that break the rules", pointing out that companies and their employees have to prepare for changes in familiar structures and mechanisms and that ongoing continuing education will keep organizations flexible enough "to master disruptions." She also said the collaborative effort with TUM will generate an important outside perspective.

Harald Krüger, member of the Supervisory Boards of Lufthansa AG and Deutsche Telekom AG, regards lifelong learning as a "strategic success factor" which requires companies to develop a positive culture of learning. He added that it is particularly important here to remain flexible and to define an objective, "To focus on impact, on benefit to the company and then simply take off running."

Infineon Technologies AG CEO Dr. Reinhard Ploss more than anything sees motivation in lifelong learning. He pointed to the need to create curiosity and enthusiasm among employees, adding that the constant transformation of basic economic and technological circumstances poses the core question: "How can I re-invent myself?"

This also applies to TUM itself: In addition, TUM IL³ will centrally address the continuing education of TUM research, teaching and administrative staff.

Campus news presse@tum.de news-36420 Mon, 25 Jan 2021 15:04:01 +0100
New Data about the structure of the Pyramid of Cheops https://www.tum.de/en/about-tum/news/press-releases/details/36418/ Research news katharina.baumeister@tum.de news-36417 Wed, 20 Jan 2021 12:52:00 +0100 Start-up Personio valued at over 1 billion dollars https://www.tum.de/en/about-tum/news/press-releases/details/36419/ Personio has announced a new round of funding, raising over 125 million dollars, and a market valuation of 1.7 billion dollars. As reported by the German daily Süddeutsche Zeitung, these successes make the provider of human resources software one of Europe’s most valuable privately owned software makers.

The term “unicorn” – referring to the rarity of the mythical creature – applies to start-ups that exceed a valuation of 1 billion dollars without a stock market listing. In Germany, in fact, only about a dozen have been spotted – but three alone at TUM: In 2018 the valuation of Celonis, which provides process mining software to analyze companies’ digital business processes, topped 1 billion dollars. In 2020 Lilium, which is developing an electric flying taxi, smashed the unicorn barrier. Both companies were established by alumni with support from TUM.

Entrepreneurship klaus.becker@tum.de news-36416 Tue, 19 Jan 2021 11:53:26 +0100
Clocking the movement of electrons inside an atom https://www.tum.de/en/about-tum/news/press-releases/details/36415/ X-ray free-electron lasers (XFELs) have delivered intense, ultrashort X-ray pulses in the femtosecond range for over a decade. A femtosecond is equivalent to a millionth of a billionth of a second.

One of the most promising applications of XFELs is in biology, where researchers can capture images down to the atomic scale even before the radiation damage destroys the sample. In physics and chemistry, these X-rays can also shed light on the fastest processes occurring in nature with a shutter speed lasting only one femtosecond.

Research news katharina.baumeister@tum.de news-36414 Mon, 18 Jan 2021 17:00:00 +0100
Highly endowed EU grants for research at TUM https://www.tum.de/en/about-tum/news/press-releases/details/36413/ Researchers at TUM have received a total of 140 prestigious ERC Grants to date. The ERC awards grants in various categories every year. Two Advanced Grants, five Starting Grants and three Proof of Concept Grants were recently awarded to TUM researchers.

Consolidator Grants are provided to researchers with between seven and 12 years' experience since completion of a doctorate, and come with up to 2 million euros in funding for their projects. The latest successful grant applicants at TUM:

Research news Quantum Technologies news-36412 Thu, 14 Jan 2021 11:19:00 +0100
Munich Quantum Valley points the way to the future https://www.tum.de/en/about-tum/news/press-releases/details/36408/ TUM President Prof. Thomas F. Hofmann highlights the significance of the new joint project: "Quantum Valley Munich builds on the outstanding achievements of Munich as the birthplace of German quantum research and, completely in line with our ONE MUNICH strategy, consolidates our wide spectrum of strengths across institutional boundaries. Together we are creating an ecosystem for quantum technologies which is among the best in the world and which will attract international scientific talents to Bavaria."

The Munich Quantum Valley partner organizations intend to move the development of quantum science and technology ahead over the next ten years on national and international levels. In addition to the Technical University of Munich, members of the initiative include the Bavarian Academy of Sciences and Humanities, Fraunhofer, Ludwig Maximilian University of Munich and the Max Planck Society.

Pending the approval of the Bavarian State Parliament, the Bavarian government plans to provide a total of 300 million euros, with 120 million euros available as early as 2021 and 2022. Munich Quantum Valley will build on this robust foundation and will apply for funding from the German federal government, which is investing two billion euros under the "Zukunftspaket Deutschland" in support of the further development of quantum technologies.

Research, development and education

The partners will found a joint Center for Quantum Computing and Quantum Technologies (ZQQ) as well as a Quantum Technology Park and will increase emphasis on training and continuing education both for talented young individuals and for established experts from the industry sector.

Science and industry will define priorities in the research and development of quantum sciences and technologies at the ZQQ and will coordinate funding for excellent projects in this area. Support could thus for example go to scientists at Bavarian research sites beyond Munich searching for new materials with quantum simulators, working on quantum metrology methods for highly precise electric and magnetic field measurements or developing interception-proof quantum cryptography processes.

In the years to come the ZQQ will also build a quantum computer capable of handling calculations which are impossible with conventional super computers. In the long term this is to serve as the basis for commercially viable quantum computers whose computing power can be made available through cloud access. The ZQQ will also create software for quantum computers and interfaces to conventional computers.

Turning research results into innovative products

At the Quantum Technology Park the Quantum Valley partners will create the high-tech infrastructure needed by research institutes, start-ups and established technology companies to develop quantum technologies at internationally competitive levels. The Quantum Technology Park will include cleanrooms with nano-production and thin-layer production equipment as well as modern development and test laboratories.

This unique infrastructure will for example also be available to researchers from start-up companies collaborating with the TUM Venture Lab Quantum, currently being set up, to turn research results into innovative products more quickly.

Training and continuing education of expert research and industry staff

The success of Munich Quantum Valley will however be contingent on outstandingly trained scientists and highly qualified experts from industry. Training will center on handling intellectual property, with quantum technology modules for curricula combining technology and management as well with programs for start-up entrepreneurs and continuing education for expert staff from the industry sector.

Bavaria and its Munich innovation hub are already among the world's leading locations for training talented young individuals in quantum science and technologies thanks to their university and non-university institutions. Munich Quantum Valley will now elevate these activities to the highest international level.

Campus news Quantum Technologies presse@tum.de news-36407 Fri, 08 Jan 2021 18:14:41 +0100
Cable robot builds and renovates facades https://www.tum.de/en/about-tum/news/press-releases/details/36406/ The robot is part of the EU project HEPHAESTUS, which promotes research into robots and autonomous systems in the construction industry. With the help of eight cables, the prototype can turn and move in all directions. In Spain, the researchers have set up a hundred square meter test stand for the first tests, which is supposed to simulate a three-story building facade.

TUM in the media news-36405 Tue, 05 Jan 2021 08:47:00 +0100